Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Spectrum Laboratory Products, Inc.
WARNING LETTER
•Spectrum Laboratory Products, Inc.•November 16, 2018

Spectrum Laboratory Products, Inc. – FDA Warning Letter, Nov 16, 2018

Record Details

The FDA inspected Spectrum Laboratory Products, Inc. (Spectrum) from November 8-16, 2018, identifying significant deviations from current good manufacturing practice (CGMP) for active pharmaceutical ingredients (API), rendering their drugs adulterated.

Key violations include: 1. **Failure to transfer complete quality/regulatory information:** Spectrum omitted original API manufacturer names and addresses on Certificates of Analysis (COA) and labels for repackaged APIs, including opioids like fentanyl citrate and morphine sulfate. This compromises supply chain accountability. The FDA requires a remediated COA program, a retrospective review of affected drugs, and examples of new COAs with original manufacturer information. 2. **Inadequate quality unit investigations:** Spectrum failed to thoroughly investigate critical deviations (e.g., a cracked Buprenorphine HCl bottle) and customer complaints (e.g., fluconazole batch variation), lacking root cause analysis and corrective actions. The FDA demands full investigation reports and a comprehensive assessment of their CAPA system.

Additionally, Spectrum commercially distributes acetylcysteine, doxylamine, pyrimethamine, tamoxifen, and trichlormethiazide, which are not listed with the FDA, making them misbranded. Opioid APIs (fentanyl citrate, hydrocodone bitartrate, buprenorphine hydrochloride, hydromorphone hydrochloride, morphine sulfate, and nalbuphine hydrochloride) are also misbranded because their labels falsely imply Spectrum is the sole manufacturer

Company
Spectrum Laboratory Products, Inc.
Inspection date
November 16, 2018
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations IV
Person
  • Steven E. Porter (Program Division Director)
View Company Profile

ID · e82f6232-6919-4024-b15a-c8dda0796972

Violation Codes7
21 U.S.C. 360(j)21 U.S.C. 331(p)21 U.S.C. 352(o)21 U.S.C. 352(a)21 CFR 201.1(h)(2)21 U.S.C. 356C(b)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for Spectrum Laboratory Products, Inc.
  • 483 - 2026-03-20March 20, 2026
  • EIR - 2021-03-12March 12, 2021
  • 483 - 2021-03-12March 12, 2021
  • WARNING_LETTER - 2019-03-12March 12, 2019
  • EIR - 2018-11-16November 16, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Spectrum Laboratory Products, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.